1. Home
  2. SQNS vs ELUT Comparison

SQNS vs ELUT Comparison

Compare SQNS & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sequans Communications S.A.

SQNS

Sequans Communications S.A.

N/A

Current Price

$2.54

Market Cap

38.0M

Sector

Technology

ML Signal

N/A

Logo Elutia Inc.

ELUT

Elutia Inc.

N/A

Current Price

$0.85

Market Cap

35.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SQNS
ELUT
Founded
2003
2015
Country
France
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.0M
35.6M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
SQNS
ELUT
Price
$2.54
$0.85
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $9.33
N/A
AVG Volume (30 Days)
57.0K
★ 104.0K
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 146.77
EPS
★ N/A
N/A
Revenue
N/A
★ $12,293,000.00
Revenue This Year
$34.42
N/A
Revenue Next Year
$60.58
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.31
$0.50
52 Week High
$6.98
$1.39

Technical Indicators

Market Signals
Indicator
SQNS
ELUT
Relative Strength Index (RSI) 40.90 54.65
Support Level $2.37 $0.75
Resistance Level $3.19 $0.87
Average True Range (ATR) 0.15 0.07
MACD 0.01 0.01
Stochastic Oscillator 38.78 82.00

Price Performance

Historical Comparison
SQNS
ELUT

About SQNS Sequans Communications S.A.

Sequans Communications SA is a fabless semiconductor company specializing in wireless 4G and 5G cellular technologies for the Internet of Things (IoT). Sequans' engineers design and develop, secure, and energy-efficient semiconductor solutions that enable the next generation of AI-connected applications, including smart energy metering, industrial automation, smart mobility and logistics, secure payments, e-health, and smart home solutions. The Company offers a comprehensive portfolio of wireless connectivity solutions, including radio frequency (RF) transceivers, integrated circuits (ICs) for baseband processing, as well as modules, software, & protocol stacks. The Company has one operating segment, which is the design & marketing of semiconductor components for cellular wireless systems.

About ELUT Elutia Inc.

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Share on Social Networks: